Cargando…
Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways
A total of ~38.6 million mortalities occur due to liver cancer annually, worldwide. Although a variety of therapeutic methods are available, the efficacy of treatment at present is extremely limited due to an increased risk of malignancy and inherently poor prognosis of liver cancer. Gene therapy is...
Autores principales: | Chen, Li-Gang, Liu, Yuan-Sheng, Zheng, Tang-Hui, Chen, Xu, Li, Ping, Xiao, Chuan-Xing, Ren, Jian-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103948/ https://www.ncbi.nlm.nih.gov/pubmed/27900002 http://dx.doi.org/10.3892/ol.2016.5114 |
Ejemplares similares
-
Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus
por: Jin, Zhongyuan, et al.
Publicado: (2021) -
Anti-Tumor Effects of an Oncolytic Adenovirus Expressing Hemagglutinin-Neuraminidase of Newcastle Disease Virus in Vitro and in Vivo
por: He, Dongyun, et al.
Publicado: (2014) -
Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016) -
Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutinin-neuraminidase proteins
por: Lee, Youn-Jeong, et al.
Publicado: (2008) -
Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan
por: MASE, Masaji
Publicado: (2021)